Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction - PubMed (original) (raw)
. 2003 Sep 12;309(1):232-40.
doi: 10.1016/s0006-291x(03)01544-4.
Takafumi Sangai, Tatsuya Oda, Yasuyuki Aoyagi, Takahiro Hasebe, Naoki Kanomata, Yasushi Endoh, Chie Okumura, Yoko Okuhara, Junji Magae, Makito Emura, Takahiro Ochiya, Atsushi Ochiai
Affiliations
- PMID: 12943687
- DOI: 10.1016/s0006-291x(03)01544-4
Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction
Genichiro Ishii et al. Biochem Biophys Res Commun. 2003.
Abstract
To confirm whether human cancer-induced stromal cells are derived from bone marrow, bone marrow (BM) cells obtained from beta-galactosidase transgenic and recombination activating gene 1 (RAG-1) deficient double-mutant mice (H-2b) were transplanted into sublethally irradiated severe combined immunodeficient (SCID) mice (H-2d). The human pancreatic cancer cell line Capan-1 was subcutaneously xenotransplanted into SCID recipients and stromal formation was analyzed on day 14 and on day 28. Immunohistochemical and immunofluorescence studies revealed that BM-derived endothelial cells (X-gal/CD31 or H-2b/CD31 double-positive cells) and myofibroblasts (X-gal/alpha-smooth muscle actin or H-2b/alpha-smooth muscle actin double-positive cells) were present within and around the cancer nests. On day 14, the frequencies of BM-derived endothelial cells and BM-derived myofibroblasts were 25.3+/-4.4% and 12.7+/-9.6%, respectively. On day 28, the frequency of BM-derived endothelial cells was 26.7+/-9.7%, which was similar to the value on day 14. However, the frequency of BM-derived myofibroblasts was significantly higher (39.8+/-17.1%) on day 28 than on day 14 (P<0.05). The topoisomerase IIalpha-positive ratio was 2.2+/-1.2% for the H-2b-positive myofibroblasts, as opposed to only 0.3+/-0.4% for the H-2b-negative myofibroblasts, significant proliferative activity was observed in the BM-derived myofibroblasts (P<0.05). Our results indicate that BM-derived myofibroblasts become a major component of cancer-induced stromal cells in the later stage of tumor development.
Similar articles
- Effect of differences in cancer cells and tumor growth sites on recruiting bone marrow-derived endothelial cells and myofibroblasts in cancer-induced stroma.
Sangai T, Ishii G, Kodama K, Miyamoto S, Aoyagi Y, Ito T, Magae J, Sasaki H, Nagashima T, Miyazaki M, Ochiai A. Sangai T, et al. Int J Cancer. 2005 Jul 20;115(6):885-92. doi: 10.1002/ijc.20969. Int J Cancer. 2005. PMID: 15729726 - Stromal fibroblast-bone marrow-derived cell interactions: implications for myofibroblast development in the cornea.
Singh V, Agrawal V, Santhiago MR, Wilson SE. Singh V, et al. Exp Eye Res. 2012 May;98(1):1-8. doi: 10.1016/j.exer.2012.03.006. Epub 2012 Mar 23. Exp Eye Res. 2012. PMID: 22465408 Free PMC article. - Involvement of bone marrow-derived stromal cells in gastrointestinal cancer development and metastasis.
Ishii S, Tsuji S, Tsujii M, Kanazawa Y, Nishida T, Iijima H, Yasumaru M, Irie T, Yamamoto K, Tsutsui S, Eguchi H, Kawano S, Hayashi N. Ishii S, et al. J Gastroenterol Hepatol. 2008 Dec;23 Suppl 2:S242-9. doi: 10.1111/j.1440-1746.2008.05446.x. J Gastroenterol Hepatol. 2008. PMID: 19120906 - Role of bone marrow-derived cells in colon cancer: lessons from mouse model studies.
Taketo MM. Taketo MM. J Gastroenterol. 2009;44(2):93-102. doi: 10.1007/s00535-008-2321-3. Epub 2009 Feb 13. J Gastroenterol. 2009. PMID: 19214670 Review. - The myofibroblast: a quarter century after its discovery.
Schürch W, Seemayer TA, Gabbiani G. Schürch W, et al. Am J Surg Pathol. 1998 Feb;22(2):141-7. doi: 10.1097/00000478-199802000-00001. Am J Surg Pathol. 1998. PMID: 9500214 Review. No abstract available.
Cited by
- Mesenchymal stem cell secretome and regenerative therapy after cancer.
Zimmerlin L, Park TS, Zambidis ET, Donnenberg VS, Donnenberg AD. Zimmerlin L, et al. Biochimie. 2013 Dec;95(12):2235-45. doi: 10.1016/j.biochi.2013.05.010. Epub 2013 Jun 5. Biochimie. 2013. PMID: 23747841 Free PMC article. Review. - Heterogeneity of cancer-associated fibroblasts: Opportunities for precision medicine.
Kanzaki R, Pietras K. Kanzaki R, et al. Cancer Sci. 2020 Aug;111(8):2708-2717. doi: 10.1111/cas.14537. Epub 2020 Jul 11. Cancer Sci. 2020. PMID: 32573845 Free PMC article. Review. - Multipotent Mesenchymal Stromal Cells: Possible Culprits in Solid Tumors?
Johann PD, Müller I. Johann PD, et al. Stem Cells Int. 2015;2015:914632. doi: 10.1155/2015/914632. Epub 2015 Jul 27. Stem Cells Int. 2015. PMID: 26273308 Free PMC article. Review. - Stromal fibroblasts in colorectal liver metastases originate from resident fibroblasts and generate an inflammatory microenvironment.
Mueller L, Goumas FA, Affeldt M, Sandtner S, Gehling UM, Brilloff S, Walter J, Karnatz N, Lamszus K, Rogiers X, Broering DC. Mueller L, et al. Am J Pathol. 2007 Nov;171(5):1608-18. doi: 10.2353/ajpath.2007.060661. Epub 2007 Oct 4. Am J Pathol. 2007. PMID: 17916596 Free PMC article. - Stem cells as vectors for antitumour therapy.
Loebinger MR, Janes SM. Loebinger MR, et al. Thorax. 2010 Apr;65(4):362-9. doi: 10.1136/thx.2009.128025. Thorax. 2010. PMID: 20388765 Free PMC article. Review.